{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T10:41:17Z","timestamp":1784371277228,"version":"3.55.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,3,14]],"date-time":"2020-03-14T00:00:00Z","timestamp":1584144000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,14]],"date-time":"2020-03-14T00:00:00Z","timestamp":1584144000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Allergy Asthma Rep"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s11882-020-00905-9","type":"journal-article","created":{"date-parts":[[2020,3,14]],"date-time":"2020-03-14T10:03:00Z","timestamp":1584180180000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["NSAID-ERD Syndrome: the New Hope from Prevention, Early Diagnosis, and New Therapeutic Targets"],"prefix":"10.1007","volume":"20","author":[{"given":"Tanya M.","family":"Laidlaw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua M.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,14]]},"reference":[{"issue":"4","key":"905_CR1","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.jaci.2006.07.024","volume":"118","author":"DD Stevenson","year":"2006","unstructured":"Stevenson DD, Szczeklik A. Clinical and pathologic perspectives on aspirin sensitivity and asthma. J Allergy Clin Immunol. 2006;118(4):773\u201386 quiz 787-778.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"905_CR2","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1056\/NEJMcibr1514013","volume":"374","author":"TM Laidlaw","year":"2016","unstructured":"Laidlaw TM, Boyce JA. Aspirin-exacerbated respiratory disease--new prime suspects. N Engl J Med. 2016;374(5):484\u20138.","journal-title":"N Engl J Med"},{"issue":"11","key":"905_CR3","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1056\/NEJMra1712125","volume":"379","author":"AA White","year":"2018","unstructured":"White AA, Stevenson DD. Aspirin-exacerbated respiratory disease. N Engl J Med. 2018;379(11):1060\u201370.","journal-title":"N Engl J Med"},{"issue":"1","key":"905_CR4","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jaci.2014.07.031","volume":"135","author":"KN Cahill","year":"2015","unstructured":"Cahill KN, Bensko JC, Boyce JA, Laidlaw TM. Prostaglandin D(2): a dominant mediator of aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2015;135(1):245\u201352.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"905_CR5","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.jaip.2013.12.003","volume":"2","author":"JC Cardet","year":"2014","unstructured":"Cardet JC, White AA, Barrett NA, Feldweg AM, Wickner PG, Savage J, et al. Alcohol-induced respiratory symptoms are common in patients with aspirin exacerbated respiratory disease. J Allergy Clin Immunol Pract. 2014;2(2):208\u201313.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"905_CR6","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/cea.12836","volume":"47","author":"E De Schryver","year":"2017","unstructured":"De Schryver E, Derycke L, Campo P, et al. Alcohol hyper-responsiveness in chronic rhinosinusitis with nasal polyps. Clin Exp Allergy.\u00a02017;47(2):245\u201353.","journal-title":"Clin Exp Allergy"},{"issue":"4","key":"905_CR7","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.jaip.2016.03.004","volume":"4","author":"R Divekar","year":"2016","unstructured":"Divekar R, Hagan J, Rank M, Park M, Volcheck G, O'Brien E, et al. Diagnostic utility of urinary LTE4 in asthma, allergic rhinitis, chronic rhinosinusitis, nasal polyps, and aspirin sensitivity. J Allergy Clin Immunol Pract. 2016;4(4):665\u201370.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"905_CR8","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/j.jaip.2018.10.032","volume":"7","author":"GA DeGregorio","year":"2019","unstructured":"\u2022\u2022 DeGregorio GA, Singer J, Cahill KN, Laidlaw T. A 1-day, 90-minute aspirin challenge and desensitization protocol in aspirin-exacerbated respiratory disease. J Allergy Clin Immunol Pract. 2019;7(4):1174\u201380. Paper describing protocol for oral aspirin challenge and desensitization.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"905_CR9","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/j.jaip.2018.08.004","volume":"7","author":"T Pelletier","year":"2019","unstructured":"Pelletier T, Roizen G, Ren Z, Hudes G, Rosenstreich D, Jerschow E. Comparable safety of 2 aspirin desensitization protocols for aspirin exacerbated respiratory disease. J Allergy Clin Immunol Pract. 2019;7(4):1319\u201321.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"905_CR10","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.iac.2012.11.002","volume":"33","author":"J Mullol","year":"2013","unstructured":"Mullol J, Picado C. Rhinosinusitis and nasal polyps in aspirin-exacerbated respiratory disease. Immunol Allergy Clin N Am. 2013;33(2):163\u201376.","journal-title":"Immunol Allergy Clin N Am"},{"key":"905_CR11","doi-asserted-by":"crossref","unstructured":"Laidlaw TM, Cahill KN, Cardet JC, et al. A trial of type 12 purinergic (P2Y12) receptor inhibition with prasugrel identifies a potentially distinct endotype of patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2018.","DOI":"10.1016\/j.jaci.2018.06.001"},{"issue":"3","key":"905_CR12","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1002\/alr.22249","volume":"9","author":"JC Morse","year":"2019","unstructured":"Morse JC, Shilts MH, Ely KA, Li P, Sheng Q, Huang LC, et al. Patterns of olfactory dysfunction in chronic rhinosinusitis identified by hierarchical cluster analysis and machine learning algorithms. Int Forum Allergy Rhinol. 2019;9(3):255\u201364.","journal-title":"Int Forum Allergy Rhinol"},{"issue":"4","key":"905_CR13","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1002\/alr.22264","volume":"9","author":"KA Smith","year":"2019","unstructured":"\u2022\u2022 Smith KA, Orlandi RR, Oakley G, Meeks H, Curtin K, Alt JA. Long-term revision rates for endoscopic sinus surgery. Int Forum Allergy Rhinol. 2019;9(4):402\u20138. Large database study describing the revision rates for endoscopic sinus surgery and the patient factors that contributed to them.","journal-title":"Int Forum Allergy Rhinol"},{"issue":"3","key":"905_CR14","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1177\/000348941112000304","volume":"120","author":"D Mendelsohn","year":"2011","unstructured":"Mendelsohn D, Jeremic G, Wright ED, Rotenberg BW. Revision rates after endoscopic sinus surgery: a recurrence analysis. Ann Otol Rhinol Laryngol. 2011;120(3):162\u20136.","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"1","key":"905_CR15","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s12931-018-0909-6","volume":"19","author":"SAA Comhair","year":"2018","unstructured":"Comhair SAA, Bochenek G, Baicker-McKee S, Wang Z, Stachura T, Sanak M, et al. The utility of biomarkers in diagnosis of aspirin exacerbated respiratory disease. Respir Res. 2018;19(1):210.","journal-title":"Respir Res"},{"key":"905_CR16","doi-asserted-by":"crossref","unstructured":"Stevens WW, Ocampo CJ, Berdnikovs S, Sakashita M, Mahdavinia M, Suh L, Takabayashi T, Norton JE, Hulse KE, Conley DB, Chandra RK, Tan BK, Peters AT, Grammer LC 3rd, Kato A, Harris KE, Carter RG, Fujieda S, Kern RC, Schleimer RP Cytokines in chronic rhinosinusitis. Role in eosinophilia and aspirin-exacerbated respiratory disease. Am J Respir Crit Care Med 2015;192(6):682\u2013694.","DOI":"10.1164\/rccm.201412-2278OC"},{"issue":"2","key":"905_CR17","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.jaci.2018.10.007","volume":"143","author":"KN Cahill","year":"2019","unstructured":"Cahill KN, Murphy K, Singer J, Israel E, Boyce JA, Laidlaw TM. Plasma tryptase elevation during aspirin-induced reactions in aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2019;143(2):799\u2013803 e792.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"905_CR18","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.jaci.2014.08.020","volume":"135","author":"JP Rajan","year":"2015","unstructured":"Rajan JP, Wineinger NE, Stevenson DD, White AA. Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: a meta-analysis of the literature. J Allergy Clin Immunol. 2015;135(3):676\u201381 e671.","journal-title":"J Allergy Clin Immunol"},{"key":"905_CR19","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/S1081-1206(10)60465-6","volume":"100","author":"AB Dursun","year":"2008","unstructured":"Dursun AB, Woessner KA, Simon RA, Karasoy D, Stevenson DD. Predicting outcomes of oral aspirin challenges in patients with asthma, nasal polyps, and chronic sinusitis. Ann Allergy\u00a0Asthma\u00a0Immunol. 2008;100:420\u20135.","journal-title":"Ann Allergy\u00a0Asthma\u00a0Immunol"},{"issue":"3","key":"905_CR20","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.jaci.2016.05.048","volume":"139","author":"KN Cahill","year":"2017","unstructured":"Cahill KN, Johns CB, Cui J, Wickner P, Bates DW, Laidlaw TM, et al. Automated identification of an aspirin-exacerbated respiratory disease cohort. J Allergy Clin Immunol. 2017;139(3):819\u201325 e816.","journal-title":"J Allergy Clin Immunol"},{"issue":"5 Pt 1","key":"905_CR21","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1164\/ajrccm\/143.5_Pt_1.1025","volume":"143","author":"PE Christie","year":"1991","unstructured":"Christie PE, Tagari P, Ford-Hutchinson AW, Charlesson S, Chee P, Arm JP, et al. Urinary leukotriene E4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects. Am Rev Respir Dis. 1991;143(5 Pt 1):1025\u20139.","journal-title":"Am Rev Respir Dis"},{"issue":"16","key":"905_CR22","doi-asserted-by":"publisher","first-page":"3790","DOI":"10.1182\/blood-2011-10-384826","volume":"119","author":"TM Laidlaw","year":"2012","unstructured":"Laidlaw TM, Kidder MS, Bhattacharyya N, Xing W, Shen S, Milne GL, et al. Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes. Blood. 2012;119(16):3790\u20138.","journal-title":"Blood."},{"issue":"1","key":"905_CR23","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jaci.2016.11.023","volume":"140","author":"JJ Eastman","year":"2017","unstructured":"Eastman JJ, Cavagnero KJ, Deconde AS, et al. Group 2 innate lymphoid cells are recruited to the nasal mucosa in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2017;140(1):101\u2013108 e103.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"905_CR24","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jaci.2011.01.065","volume":"128","author":"J Roca-Ferrer","year":"2011","unstructured":"Roca-Ferrer J, Garcia-Garcia FJ, Pereda J, Perez-Gonzalez M, Pujols L, Alobid I, et al. Reduced expression of COXs and production of prostaglandin E(2) in patients with nasal polyps with or without aspirin-intolerant asthma. J Allergy Clin Immunol. 2011;128(1):66\u201372 e61.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"905_CR25","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.jaci.2005.10.037","volume":"117","author":"S Ying","year":"2006","unstructured":"Ying S, Meng Q, Scadding G, Parikh A, Corrigan CJ, Lee TH. Aspirin-sensitive rhinosinusitis is associated with reduced E-prostanoid 2 receptor expression on nasal mucosal inflammatory cells. J Allergy Clin Immunol. 2006;117(2):312\u20138.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"905_CR26","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jaci.2015.09.028","volume":"137","author":"L Machado-Carvalho","year":"2016","unstructured":"Machado-Carvalho L, Martin M, Torres R, et al. Low E-prostanoid 2 receptor levels and deficient induction of the IL-1beta\/IL-1 type I receptor\/COX-2 pathway: vicious circle in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2016;137(1):99\u2013107 e107.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"905_CR27","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/ni.3123","volume":"16","author":"A Iwasaki","year":"2015","unstructured":"Iwasaki A, Medzhitov R. Control of adaptive immunity by the innate immune system. Nat Immunol. 2015;16(4):343\u201353.","journal-title":"Nat Immunol"},{"issue":"8","key":"905_CR28","doi-asserted-by":"publisher","first-page":"3537","DOI":"10.4049\/jimmunol.1500905","volume":"195","author":"T Liu","year":"2015","unstructured":"Liu T, Kanaoka Y, Barrett NA, et al. Aspirin-exacerbated respiratory disease involves a cysteinyl leukotriene-driven IL-33-mediated mast cell activation pathway. J Immunol. 2015;195(8):3537\u201345.","journal-title":"J Immunol"},{"issue":"5","key":"905_CR29","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1016\/j.jaci.2015.10.020","volume":"137","author":"KM Buchheit","year":"2016","unstructured":"Buchheit KM, Cahill KN, Katz HR, Murphy KC, Feng C, Lee-Sarwar K, et al. Thymic stromal lymphopoietin controls prostaglandin D2 generation in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2016;137(5):1566\u2013s.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"905_CR30","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.jaip.2015.03.001","volume":"3","author":"V Ta","year":"2015","unstructured":"Ta V, White AA. Survey-defined patient experiences with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol Pract. 2015;3(5):711\u20138.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"905_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaci.2016.12.924","volume":"139","author":"TM Laidlaw","year":"2017","unstructured":"Laidlaw TM, Fuentes DJ, Want Y. Efficacy of zileuton in patients with asthma and history of aspirin sensitivity: a retrospective analysis of data from two phase 3 studies. J Allergy Clin Immunol. 2017;139(2):1.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"905_CR32","doi-asserted-by":"publisher","first-page":"573","DOI":"10.2500\/ajr.2006.20.2913","volume":"20","author":"KC McMains","year":"2006","unstructured":"McMains KC, Kountakis SE. Medical and surgical considerations in patients with Samter's triad. Am J Rhinol. 2006;20(6):573\u20136.","journal-title":"Am J Rhinol"},{"issue":"9","key":"905_CR33","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1111\/j.1398-9995.2008.01658.x","volume":"63","author":"A Rozsasi","year":"2008","unstructured":"Rozsasi A, Polzehl D, Deutschle T, et al. Long-term treatment with aspirin desensitization: a prospective clinical trial comparing 100 and 300 mg aspirin daily. Allergy. 2008;63(9):1228\u201334.","journal-title":"Allergy."},{"key":"905_CR34","doi-asserted-by":"crossref","unstructured":"Berges-Gimeno MP, Simon RA, Stevenson DD. Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol 2003;111(1):180\u2013186.","DOI":"10.1067\/mai.2003.7"},{"issue":"6","key":"905_CR35","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1164\/rccm.201809-1755OC","volume":"200","author":"KN Cahill","year":"2019","unstructured":"Cahill KN, Cui J, Kothari P, Murphy K, Raby BA, Singer J, et al. Unique effect of aspirin therapy on biomarkers in aspirin-exacerbated respiratory disease. A prospective trial. Am J Respir Crit Care Med. 2019;200(6):704\u201311.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"905_CR36","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.jaip.2017.10.011","volume":"6","author":"TR Schneider","year":"2018","unstructured":"Schneider TR, Johns CB, Palumbo ML, Murphy KC, Cahill KN, Laidlaw TM. Dietary fatty acid modification for the treatment of aspirin-exacerbated respiratory disease: a prospective pilot trial. J Allergy Clin Immunol Pract. 2018;6(3):825\u201331.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"Suppl 1","key":"905_CR37","first-page":"S22","volume":"6","author":"RR Orlandi","year":"2016","unstructured":"Orlandi RR, Kingdom TT, Smith TL, et al. International consensus statement on allergy and rhinology: rhinosinusitis. Int Forum\u00a0Allergy\u00a0Rhinol. 2016;6(Suppl 1):S22\u2013209.","journal-title":"Int Forum\u00a0Allergy\u00a0Rhinol"},{"key":"905_CR38","unstructured":"Jerschow E, Edin ML, Chi Y, et al. Sinus surgery is associated with a decrease in aspirin-induced reaction severity in AERD patients. J Allergy Clin Immunol Pract. 2018."},{"key":"905_CR39","doi-asserted-by":"crossref","unstructured":"Huang GX, Palumbo ML, Singer JI, Cahill KN, Laidlaw TM. Sinus surgery improves lower respiratory reactivity during aspirin desensitization for AERD. J Allergy Clin Immunol Pract. 2019;7(5):1647\u20131649.","DOI":"10.1016\/j.jaip.2019.02.037"},{"issue":"6","key":"905_CR40","first-page":"557","volume":"6","author":"L Rudmik","year":"2016","unstructured":"Rudmik L, Soler ZM, Hopkins C, Schlosser RJ, Peters A, White AA, et al. Defining appropriateness criteria for endoscopic sinus surgery during management of uncomplicated adult chronic rhinosinusitis: a RAND\/UCLA appropriateness study. Int Forum\u00a0Allergy\u00a0Rhinol. 2016;6(6):557\u201367.","journal-title":"Int Forum\u00a0Allergy\u00a0Rhinol"},{"key":"905_CR41","unstructured":"Lothrop HA. XIV. Frontal sinus suppuration: the establishment of permanent nasal drainage; the closure of external fistulae; epidermization of sinus. Ann Surg 1914;59(6):937\u2013957."},{"key":"905_CR42","first-page":"549","volume":"6","author":"LS Timothy","year":"2016","unstructured":"Timothy LS. The endoscopic modified Lothrop procedure: finally ready for prime time in the management of inflammatory sinus disease. Int Forum\u00a0Allergy\u00a0Rhinol. 2016;6:549.","journal-title":"Int Forum\u00a0Allergy\u00a0Rhinol"},{"issue":"3","key":"905_CR43","first-page":"238","volume":"6","author":"HP Barham","year":"2016","unstructured":"Barham HP, Ramakrishnan VR, Knisely A, Do TQ, Chan LS, Gunaratne DA, et al. Frontal sinus surgery and sinus distribution of nasal irrigation. Int Forum\u00a0Allergy\u00a0Rhinol. 2016;6(3):238\u201342.","journal-title":"Int Forum\u00a0Allergy\u00a0Rhinol"},{"issue":"1","key":"905_CR44","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/lary.24258","volume":"124","author":"Y Naidoo","year":"2014","unstructured":"Naidoo Y, Bassiouni A, Keen M, Wormald PJ. Long-term outcomes for the endoscopic modified Lothrop\/Draf III procedure: a 10-year review. Laryngoscope. 2014;124(1):43\u20139.","journal-title":"Laryngoscope."},{"key":"905_CR45","first-page":"820","volume":"6","author":"DK Morrissey","year":"2016","unstructured":"Morrissey DK, Psaltis AJ, Wormald P-J. Outcomes of modified endoscopic Lothrop in aspirin-exacerbated respiratory disease with nasal polyposis. Int Forum\u00a0Allergy\u00a0Rhinol. 2016;6:820\u20135.","journal-title":"Int Forum\u00a0Allergy\u00a0Rhinol"},{"issue":"10","key":"905_CR46","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1056\/NEJMoa0808991","volume":"360","author":"P Haldar","year":"2009","unstructured":"Haldar P, Brightling CE, Hargadon B, Gupta S, Monteiro W, Sousa A, et al. Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med. 2009;360(10):973\u201384.","journal-title":"N Engl J Med"},{"issue":"1","key":"905_CR47","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jaci.2018.08.031","volume":"143","author":"W Busse","year":"2019","unstructured":"Busse W, Chupp G, Nagase H, Albers FC, Doyle S, Shen Q, et al. Anti-IL-5 treatments in patients with severe asthma by blood eosinophil thresholds: indirect treatment comparison. J Allergy Clin Immunol. 2019;143(1):190\u2013200 e120.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"905_CR48","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/S2213-2600(18)30406-5","volume":"7","author":"WW Busse","year":"2019","unstructured":"Busse WW, Bleecker ER, FitzGerald JM, et al. Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial. Lancet Respir Med. 2019;7(1):46\u201359.","journal-title":"Lancet Respir Med"},{"issue":"3","key":"905_CR49","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.jaip.2018.01.038","volume":"6","author":"KL Tuttle","year":"2018","unstructured":"Tuttle KL, Buchheit KM, Laidlaw TM, Cahill KN. A retrospective analysis of mepolizumab in subjects with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol Pract. 2018;6(3):1045\u20137.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"905_CR50","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.jaci.2011.07.056","volume":"128","author":"P Gevaert","year":"2011","unstructured":"Gevaert P, Van Bruaene N, Cattaert T, et al. Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis. J Allergy Clin Immunol. 2011;128(5):989\u2013995 e981\u2013988.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"905_CR51","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.jaci.2017.05.044","volume":"140","author":"C Bachert","year":"2017","unstructured":"Bachert C, Sousa AR, Lund VJ, Scadding GK, Gevaert P, Nasser S, et al. Reduced need for surgery in severe nasal polyposis with mepolizumab: randomized trial. J Allergy Clin Immunol. 2017;140(4):1024\u20131031 e1014.","journal-title":"J Allergy Clin Immunol"},{"issue":"26","key":"905_CR52","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1056\/NEJMoa1804092","volume":"378","author":"M Castro","year":"2018","unstructured":"Castro M, Corren J, Pavord ID, Maspero J, Wenzel S, Rabe KF, et al. Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma. N Engl J Med. 2018;378(26):2486\u201396.","journal-title":"N Engl J Med"},{"issue":"26","key":"905_CR53","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1056\/NEJMoa1804093","volume":"378","author":"KF Rabe","year":"2018","unstructured":"Rabe KF, Nair P, Brusselle G, et al. Efficacy and safety of dupilumab in glucocorticoid-dependent severe asthma. N Engl J Med. 2018;378(26):2475\u201385.","journal-title":"N Engl J Med"},{"issue":"5","key":"905_CR54","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1001\/jama.2015.19330","volume":"315","author":"C Bachert","year":"2016","unstructured":"Bachert C, Mannent L, Naclerio RM, et al. Effect of subcutaneous dupilumab on nasal polyp burden in patients with chronic sinusitis and nasal polyposis: a randomized clinical trial. JAMA. 2016;315(5):469\u201379.","journal-title":"JAMA."},{"issue":"10209","key":"905_CR55","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1016\/S0140-6736(19)31881-1","volume":"394","author":"C Bachert","year":"2019","unstructured":"Bachert C, Han JK, Desrosiers M, Hellings PW, Amin N, Lee SE, et al. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials. Lancet. 2019;394(10209):1638\u201350.","journal-title":"Lancet."},{"key":"905_CR56","doi-asserted-by":"crossref","unstructured":"Laidlaw TM, Mullol J, Fan C, Zhang D, Amin N, Khan A, et al. Dupilumab improves nasal polyp burden and asthma control in patients with CRSwNP and AERD. J Allergy Clin Immunol Pract. 2019;7(7):2462\u20135 e2461. Study showing that dupilumab can reduce nasal polyp burden and improve sense of smell, asthma control and quality of life in patients with AERD.","DOI":"10.1016\/j.jaip.2019.03.044"},{"issue":"10","key":"905_CR57","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1056\/NEJMoa1704064","volume":"377","author":"J Corren","year":"2017","unstructured":"Corren J, Parnes JR, Wang L, Mo M, Roseti SL, Griffiths JM, et al. Tezepelumab in adults with uncontrolled asthma. N Engl J Med. 2017;377(10):936\u201346.","journal-title":"N Engl J Med"},{"issue":"22","key":"905_CR58","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1056\/NEJMoa1402895","volume":"370","author":"GM Gauvreau","year":"2014","unstructured":"Gauvreau GM, O'Byrne PM, Boulet LP, Wang Y, Cockcroft D, Bigler J, et al. Effects of an anti-TSLP antibody on allergen-induced asthmatic responses. N Engl J Med. 2014;370(22):2102\u201310.","journal-title":"N Engl J Med"},{"issue":"10","key":"905_CR59","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1016\/j.rmed.2010.04.017","volume":"104","author":"M Kupczyk","year":"2010","unstructured":"Kupczyk M, Kurmanowska Z, Kuprys-Lipinska I, Bochenska-Marciniak M, Kuna P. Mediators of inflammation in nasal lavage from aspirin intolerant patients after aspirin challenge. Respir Med. 2010;104(10):1404\u20139.","journal-title":"Respir Med"},{"issue":"11","key":"905_CR60","doi-asserted-by":"publisher","first-page":"5061","DOI":"10.4049\/jimmunol.1402959","volume":"194","author":"T Liu","year":"2015","unstructured":"Liu T, Garofalo D, Feng C, et al. Platelet-driven leukotriene C4-mediated airway inflammation in mice is aspirin-sensitive and depends on T prostanoid receptors. J Immunol. 2015;194(11):5061\u20138.","journal-title":"J Immunol"},{"issue":"3","key":"905_CR61","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41385-019-0134-8","volume":"12","author":"T Liu","year":"2019","unstructured":"Liu T, Barrett NA, Kanaoka Y, et al. Cysteinyl leukotriene receptor 2 drives lung immunopathology through a platelet and high mobility box 1-dependent mechanism. Mucosal Immunol. 2019;12(3):679\u201390.","journal-title":"Mucosal Immunol"}],"container-title":["Current Allergy and Asthma Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-020-00905-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11882-020-00905-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-020-00905-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,14]],"date-time":"2021-03-14T00:49:44Z","timestamp":1615682984000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11882-020-00905-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,14]]},"references-count":61,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["905"],"URL":"https:\/\/doi.org\/10.1007\/s11882-020-00905-9","relation":{},"ISSN":["1529-7322","1534-6315"],"issn-type":[{"value":"1529-7322","type":"print"},{"value":"1534-6315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,14]]},"assertion":[{"value":"14 March 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethics Guidelines"}},{"value":"Dr. Laidlaw reports personal fees from Regeneron, personal fees from Sanofi, personal fees from GlaxoSmithKline, outside the submitted work, Dr. Lev declares no conflicts of interest relevant to this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"10"}}